• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征(PCOS)中竞争性内源性RNA网络的生物标志物潜力

Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).

作者信息

Heidarzadehpilehrood Roozbeh, Pirhoushiaran Maryam

机构信息

Department of Obstetrics & Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran.

出版信息

Noncoding RNA Res. 2024 Jan 17;9(2):624-640. doi: 10.1016/j.ncrna.2024.01.002. eCollection 2024 Jun.

DOI:10.1016/j.ncrna.2024.01.002
PMID:38571815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10988127/
Abstract

Polycystic ovary syndrome (PCOS) is the most common condition affecting women of reproductive age globally. PCOS continues to be the largest contributing factor to female infertility despite significant progress in our knowledge of the molecular underpinnings and treatment of the condition. The fact that PCOS is a very diverse condition makes it one of the key reasons why we haven't been able to overcome it. Non-coding RNAs (ncRNAs) are implicated in the development of PCOS, according to growing evidence. However, it is unclear how the complex regulatory relationships between the many ncRNA types contribute to the growth of this malignancy. Competing endogenous RNA (ceRNA), a recently identified mechanism in the RNA world, suggests regulatory interactions between various RNAs, including long non-coding RNAs (lncRNAs), microRNAs (miRNAs), transcribed pseudogenes, and circular RNAs (circRNAs). Recent studies on PCOS have shown that dysregulation of multiple ceRNA networks (ceRNETs) between these ncRNAs plays crucial roles in developing the defining characteristics of PCOS development. And it is believed that such a finding may open a new door for a deeper comprehension of PCOS's unexplored facets. In addition, it may be able to provide fresh biomarkers and effective therapy targets for PCOS. This review will go over the body of information that exists about the primary roles of ceRNETs before highlighting the developing involvement of several newly found ceRNETs in a number of PCOS characteristics.

摘要

多囊卵巢综合征(PCOS)是全球影响育龄女性的最常见病症。尽管我们在该病症的分子基础和治疗方面取得了重大进展,但PCOS仍然是女性不孕的最大促成因素。PCOS是一种非常多样化的病症,这一事实是我们一直无法攻克它的关键原因之一。越来越多的证据表明,非编码RNA(ncRNA)与PCOS的发生有关。然而,尚不清楚多种ncRNA类型之间复杂的调控关系如何促成这种病症的发展。竞争性内源RNA(ceRNA)是RNA世界中最近发现的一种机制,它表明了包括长链非编码RNA(lncRNA)、微小RNA(miRNA)、转录假基因和环状RNA(circRNA)在内的各种RNA之间的调控相互作用。最近关于PCOS的研究表明,这些ncRNA之间多个ceRNA网络(ceRNET)的失调在PCOS发展的特征形成中起着关键作用。并且人们认为,这一发现可能为更深入理解PCOS尚未探索的方面打开一扇新的大门。此外,它或许能够为PCOS提供新的生物标志物和有效的治疗靶点。本综述将梳理有关ceRNET主要作用的现有信息,然后重点介绍一些新发现的ceRNET在多种PCOS特征中不断发展的作用。

相似文献

1
Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).多囊卵巢综合征(PCOS)中竞争性内源性RNA网络的生物标志物潜力
Noncoding RNA Res. 2024 Jan 17;9(2):624-640. doi: 10.1016/j.ncrna.2024.01.002. eCollection 2024 Jun.
2
Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.构建竞争性内源性RNA网络以鉴定多囊卵巢综合征的药物靶点
Hum Reprod. 2022 Nov 24;37(12):2856-2866. doi: 10.1093/humrep/deac218.
3
Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.竞争性内源 RNA(ceRNA)对话与 ceRNA 调控网络中的语言:乳腺癌标志物的新视角。
J Cell Physiol. 2019 Jul;234(7):10080-10100. doi: 10.1002/jcp.27941. Epub 2018 Dec 10.
4
Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.鉴定胶质母细胞瘤中失调的竞争性内源性 RNA 网络:改善治疗机会的一种途径。
Life Sci. 2021 Jul 15;277:119488. doi: 10.1016/j.lfs.2021.119488. Epub 2021 Apr 19.
5
Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks.阐明 SARS-CoV-2 的致病作用:竞争性内源性 RNA(ceRNA)调控网络的见解。
Infect Genet Evol. 2024 Aug;122:105613. doi: 10.1016/j.meegid.2024.105613. Epub 2024 Jun 4.
6
Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征中的非编码 RNA:系统评价和荟萃分析。
Reprod Biol Endocrinol. 2021 Jan 14;19(1):10. doi: 10.1186/s12958-020-00687-9.
7
WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.加权基因共表达网络分析(WGCNA)鉴定出与多囊卵巢综合征相关的环状RNA,这些环状RNA与RNA结合蛋白相互作用并作为微小RNA(miRNA)的海绵。
Int J Gen Med. 2021 Nov 23;14:8737-8751. doi: 10.2147/IJGM.S335108. eCollection 2021.
8
The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.miRNA、lncRNA 和环状 RNA 在多囊卵巢综合征发病机制中的作用:文献综述。
Int J Mol Sci. 2024 Jan 11;25(2):903. doi: 10.3390/ijms25020903.
9
Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks.多囊卵巢综合征中外泌体长链非编码 RNA 和信使 RNA 谱:生物信息学分析揭示疾病相关网络。
Reprod Biomed Online. 2022 May;44(5):777-790. doi: 10.1016/j.rbmo.2022.01.007. Epub 2022 Jan 31.
10
Role of ceRNAs in non-tumor female reproductive diseases†.ceRNAs在非肿瘤性女性生殖系统疾病中的作用†
Biol Reprod. 2023 Mar 13;108(3):363-381. doi: 10.1093/biolre/ioac200.

引用本文的文献

1
The safety and efficacy of liraglutide combined with metformin in clinical treatment of polycystic ovary syndrome patients: a meta-analysis.利拉鲁肽联合二甲双胍对多囊卵巢综合征患者临床治疗的安全性及有效性:一项荟萃分析
BMC Womens Health. 2025 Jun 6;25(1):282. doi: 10.1186/s12905-025-03787-z.
2
The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome.N6-甲基腺苷(m6A)失调在多囊卵巢综合征中的新作用。
J Ovarian Res. 2025 May 23;18(1):107. doi: 10.1186/s13048-025-01690-7.
3
SRC involves in lysosomal function and regulates ferroptosis in polycystic ovary syndrome.

本文引用的文献

1
Dysregulation of circular RNAs in inflammation and cancers.环状RNA在炎症和癌症中的失调。
Fundam Res. 2023 Jul 2;3(5):683-691. doi: 10.1016/j.fmre.2023.04.019. eCollection 2023 Sep.
2
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.通过通路富集分析和枢纽基因- microRNA网络揭示多囊卵巢综合征(PCOS)的关键生物标志物和治疗药物
Iran J Pharm Res. 2023 Nov 20;22(1):e139985. doi: 10.5812/ijpr-139985. eCollection 2023 Jan-Dec.
3
Functions of Circular RNA in Human Diseases and Illnesses.
SRC参与溶酶体功能,并调节多囊卵巢综合征中的铁死亡。
J Ovarian Res. 2025 Mar 5;18(1):42. doi: 10.1186/s13048-025-01637-y.
4
Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets.多囊卵巢综合征中的血浆微小RNA驱动子宫内膜癌进展:对分子途径和治疗靶点的见解
Discov Oncol. 2025 Feb 7;16(1):133. doi: 10.1007/s12672-025-01861-4.
5
Vitamin D receptor (VDR) gene polymorphisms and risk for polycystic ovary syndrome and infertility: An updated systematic review and meta-analysis.维生素D受体(VDR)基因多态性与多囊卵巢综合征及不孕症风险:一项更新的系统评价和荟萃分析
Metabol Open. 2024 Dec 31;25:100343. doi: 10.1016/j.metop.2024.100343. eCollection 2025 Mar.
6
The Role of the Liver in the Pathophysiology of PCOS: A Literature Review.肝脏在多囊卵巢综合征病理生理学中的作用:文献综述
Biomolecules. 2025 Jan 2;15(1):51. doi: 10.3390/biom15010051.
7
Upregulated PCAT-1 predicts poor prognosis and reduced immune cell infiltration in head and neck squamous cell carcinoma through the miR-145-5p / FSCN-1 axis.上调的PCAT-1通过miR-145-5p/FSCN-1轴预测头颈部鳞状细胞癌的不良预后并减少免疫细胞浸润。
Mol Biol Rep. 2025 Jan 13;52(1):121. doi: 10.1007/s11033-024-10208-1.
8
Whole transcriptome analysis and construction of gene regulatory networks of granulosa cells from patients with polycystic ovary syndrome (PCOS).多囊卵巢综合征(PCOS)患者颗粒细胞的全转录组分析及基因调控网络构建
Eur J Med Res. 2025 Jan 7;30(1):9. doi: 10.1186/s40001-024-02237-0.
9
Multifaceted role of microRNA-301a in human cancer: from biomarker potential to therapeutic targeting.微小RNA-301a在人类癌症中的多方面作用:从生物标志物潜力到治疗靶点
Cancer Gene Ther. 2024 Dec;31(12):1754-1764. doi: 10.1038/s41417-024-00832-1. Epub 2024 Sep 24.
环状RNA在人类疾病中的作用
Noncoding RNA. 2023 Jul 4;9(4):38. doi: 10.3390/ncrna9040038.
4
Exosomal circ_0008285 in follicle fluid regulates the lipid metabolism through the miR-4644/ LDLR axis in polycystic ovary syndrome.囊泡 circ_0008285 在卵泡液中通过 miR-4644/LDLR 轴调节多囊卵巢综合征的脂质代谢。
J Ovarian Res. 2023 Jun 15;16(1):113. doi: 10.1186/s13048-023-01199-x.
5
Amplifying gene expression with RNA-targeted therapeutics.利用 RNA 靶向治疗技术增强基因表达。
Nat Rev Drug Discov. 2023 Jul;22(7):539-561. doi: 10.1038/s41573-023-00704-7. Epub 2023 May 30.
6
A pan-cancer analysis of the role of in human tumors.在人类肿瘤中分析 的泛癌症作用。
Biotechnol Genet Eng Rev. 2024 Nov;40(3):1456-1471. doi: 10.1080/02648725.2023.2194077. Epub 2023 Mar 27.
7
Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome.加权基因共表达网络分析(WGCNA)发现了多囊卵巢综合征的新型长链非编码RNA。
Biomedicines. 2023 Feb 10;11(2):518. doi: 10.3390/biomedicines11020518.
8
Circ_0115118 regulates endometrial functions through the miR-138-1-3p/WDFY2 axis in patients with PCOS†.Circ_0115118通过miR-138-1-3p/WDFY2轴调节多囊卵巢综合征患者的子宫内膜功能†
Biol Reprod. 2023 May 10;108(5):744-757. doi: 10.1093/biolre/ioad017.
9
LncRNA HAGLR May Aggravate Melanoma Malignancy Via miR-4644/ASB11 Pathway.长链非编码 RNA HAGLR 可通过 miR-4644/ASB11 通路加重黑色素瘤恶性程度。
Mol Biotechnol. 2023 Oct;65(10):1619-1631. doi: 10.1007/s12033-023-00672-8. Epub 2023 Feb 3.
10
RNA-binding proteins in autoimmunity: From genetics to molecular biology.自身免疫中的 RNA 结合蛋白:从遗传学到分子生物学。
Wiley Interdiscip Rev RNA. 2023 Jul-Aug;14(4):e1772. doi: 10.1002/wrna.1772. Epub 2023 Jan 19.